Vascular Diseases

Revolutionizing Treatment for Vascular Conditions

Morenova introduces groundbreaking large-area shockwave therapy (LAST) for vascular diseases, offering innovative solutions for chronic wound healing and peripheral arterial disease (PAD).

Treatment Applications

Morenova offers innovative solutions for vascular diseases, providing effective treatments for chronic wound healing and PAD. With its advanced shockwave technology and targeted therapy approach, Morenova aims to improve patient outcomes and enhance vascular health.

Chronic Wound Healing (CWH)

Chronic wounds, such as diabetic foot ulcers (DFU), pose significant challenges to patients and healthcare providers alike. Morenova’s advanced shockwave therapy targets these wounds by stimulating vascular activity and promoting tissue regeneration. By broadening existing blood vessels (neovascularization) and encouraging the formation of new ones (angiogenesis), Morenova accelerates the healing process.

Morenova utilizes the Large Area Shockwave Transducer (LAST), which covers the entire wound area and surrounding tissue in a single application. This novel approach allows for simultaneous treatment of the entire wound area, enhancing the effectiveness of therapy. Unlike standard treatments that focus solely on wound management, Morenova addresses the root cause, reducing the risk of amputations and improving patient outcomes.

Peripheral Arterial Disease (PAD)

PAD, characterized by reduced blood flow to the extremities, presents significant health risks, particularly in elderly individuals and those with underlying health conditions such as diabetes. Morenova offers a multifaceted approach to PAD treatment, aiming to improve blood flow and mitigate the complications associated with inadequate circulation. By applying shockwaves along the lower leg, Morenova promotes angiogenesis, enhancing vascular function and restoring optimal blood flow.

Morenova’s unique transducer technology enables targeted treatment of arterial plaque buildup, improving artery flexibility and facilitating increased blood flow to the affected areas. This treatment aims to alleviate ischemic leg symptoms and enhance patients’ overall vascular health.

Proven Success and Risk-Free

Morenova offers a revolutionary solution for vascular disease management supported by extensive research and proven effectiveness. With a flawless safety record and high patient satisfaction, it marks a significant advancement in vascular healthcare.

Comprehensive Coverage

Morenova can address large wound areas and surrounding tissues, providing holistic treatment for chronic wounds.

Non-Invasive & Painless

Patients benefit from a safe and pain-free treatment experience, with no downtime or unpleasant side effects.

Focused Transducer Technology

Morenova's specialized transducers enable precise targeting of plaque buildup in PAD, improving arterial flexibility and blood flow without disrupting surrounding tissues.

Stimulation of Vascular Activity

By inducing neovascularization and angiogenesis, Morenova promotes the formation of new blood vessels, enhancing blood flow to affected areas.

Clinical Results

Selected Case Studies for Diabetic Foot Ulcer

Case Report –Treating DFU by Dr Robinson

Prospective Randomized Phase II Trial of Accelerated Reepithelialization of Superficial Second-Degree Burn Wounds Using Extracorporeal Shock Wave Therapy

Effects of Shock Waves on Microcirculation, Perfusion, and Pain Management in Critical Limb Ischemia

Extracorporeal Shock Wave Therapy for Treating Foot Ulcers in Adults With Type 1 and Type 2 Diabetes A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Low Intensity Shockwave Treatment Modulates Macrophage Functions Beneficial to Healing Chronic Wounds

Prospective Randomized Trial of Accelerated Re-epithelization of Skin Graft Donor Sites Using Extracorporeal Shock Wave Therapy

A Systematic Review of Extracorporeal Shockwave Therapy as a Novel Treatment for Intermittent Claudication

Evaluation of the Effects of Extracorporeal Shockwave Therapy in Patients With Peripheral Arterial Disease A Meta-Analysis of Randomized Control Trials

Low-Energy Extracorporeal Shock Wave Therapy Improves Microcirculation Blood Flow of Ischemic Limbs in Patients with Peripheral Arterial Disease Pilot Study